Bladder cancer is extremely common in the United States and extremely costly because of the high cost of surveillance.
In some patients, office-based surveillance may be a safe, cost-reducing alternative. This article attempts to identify ideal candidates and highlights surveillance strategies that can be employed in an office-based setting.
Written by:
Meeks JJ, Herr HW. Are you the author?
Department of Urology, Northwestern University, Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 16-703, Chicago, IL 60611, USA.
Reference: Urol Clin North Am. 2013 Nov;40(4):473-9.
doi: 10.1016/j.ucl.2013.07.004
PubMed Abstract
PMID: 24182970
UroToday.com Bladder Cancer Section
